BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 18501572)

  • 1. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.
    San Román B; Irache JM; Gómez S; Tsapis N; Gamazo C; Espuelas MS
    Eur J Pharm Biopharm; 2008 Sep; 70(1):98-108. PubMed ID: 18501572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems.
    Mohanan D; Slütter B; Henriksen-Lacey M; Jiskoot W; Bouwstra JA; Perrie Y; Kündig TM; Gander B; Johansen P
    J Control Release; 2010 Nov; 147(3):342-9. PubMed ID: 20727926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation.
    Wang Q; Tan MT; Keegan BP; Barry MA; Heffernan MJ
    Biomaterials; 2014 Sep; 35(29):8385-93. PubMed ID: 24986256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant delivery of a CTL-restricted peptide antigen and CpG ODN by PLGA microparticles induces cellular immune response.
    Fischer S; Schlosser E; Mueller M; Csaba N; Merkle HP; Groettrup M; Gander B
    J Drug Target; 2009 Sep; 17(8):652-61. PubMed ID: 19622019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-encapsulated CpG oligodeoxynucleotides and ovalbumin in PLGA microparticles; an in vitro and in vivo study.
    San Román B; Gómez S; Irache JM; Espuelas S
    J Pharm Pharm Sci; 2014; 17(4):541-53. PubMed ID: 25579433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diaminosulfide based polymer microparticles as cancer vaccine delivery systems.
    Geary SM; Hu Q; Joshi VB; Bowden NB; Salem AK
    J Control Release; 2015 Dec; 220(Pt B):682-90. PubMed ID: 26359124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.
    Slütter B; Bal S; Keijzer C; Mallants R; Hagenaars N; Que I; Kaijzel E; van Eden W; Augustijns P; Löwik C; Bouwstra J; Broere F; Jiskoot W
    Vaccine; 2010 Aug; 28(38):6282-91. PubMed ID: 20638455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-delivery of ovalbumin and CpG motifs into microparticles protected sensitized mice from anaphylaxis.
    San Román B; Irache JM; Gómez S; Gamazo C; Espuelas S
    Int Arch Allergy Immunol; 2009; 149(2):111-8. PubMed ID: 19127067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of a balanced Th1/Th2 immune responses by co-delivery of PLGA/ovalbumin nanospheres and CpG ODNs/PEI-SWCNT nanoparticles as TLR9 agonist in BALB/c mice.
    Ebrahimian M; Hashemi M; Maleki M; Abnous K; Hashemitabar G; Ramezani M; Haghparast A
    Int J Pharm; 2016 Dec; 515(1-2):708-720. PubMed ID: 27989827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-encapsulation of antigen and Toll-like receptor ligand in cationic liposomes affects the quality of the immune response in mice after intradermal vaccination.
    Bal SM; Hortensius S; Ding Z; Jiskoot W; Bouwstra JA
    Vaccine; 2011 Jan; 29(5):1045-52. PubMed ID: 21129393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a poly (lactic-co-glycolic acid) particle vaccine to protect against house dust mite induced allergy.
    Joshi VB; Adamcakova-Dodd A; Jing X; Wongrakpanich A; Gibson-Corley KN; Thorne PS; Salem AK
    AAPS J; 2014 Sep; 16(5):975-85. PubMed ID: 24981892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Encapsulation of antigen in poly(D,L-lactide-co-glycolide) microspheres protects from harmful effects of γ-irradiation as assessed in mice.
    Mohanan D; Gander B; Kündig TM; Johansen P
    Eur J Pharm Biopharm; 2012 Feb; 80(2):274-81. PubMed ID: 22024408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.
    Wusiman A; Gu P; Liu Z; Xu S; Zhang Y; Hu Y; Liu J; Wang D; Huang X
    Int J Nanomedicine; 2019; 14():3221-3234. PubMed ID: 31123399
    [No Abstract]   [Full Text] [Related]  

  • 14. Surface modification of poly(D,L-lactic-co-glycolic acid) nanoparticles with protamine enhanced cross-presentation of encapsulated ovalbumin by bone marrow-derived dendritic cells.
    Han R; Zhu J; Yang X; Xu H
    J Biomed Mater Res A; 2011 Jan; 96(1):142-9. PubMed ID: 21105162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-Responsive Poly(D,L-lactic-co-glycolic acid) Nanoparticles with Rapid Antigen Release Behavior Promote Immune Response.
    Liu Q; Chen X; Jia J; Zhang W; Yang T; Wang L; Ma G
    ACS Nano; 2015 May; 9(5):4925-38. PubMed ID: 25898266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inverse micellar sugar glass (IMSG) nanoparticles for transfollicular vaccination.
    Mittal A; Schulze K; Ebensen T; Weissmann S; Hansen S; Guzmán CA; Lehr CM
    J Control Release; 2015 May; 206():140-52. PubMed ID: 25795506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of protein-adjuvant coencapsulation in microparticles for vaccine delivery.
    Mathew S; Lendlein A; Wischke C
    Eur J Pharm Biopharm; 2014 Jul; 87(2):403-7. PubMed ID: 24747810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface coating of PLGA microparticles with protamine enhances their immunological performance through facilitated phagocytosis.
    Martínez Gómez JM; Csaba N; Fischer S; Sichelstiel A; Kündig TM; Gander B; Johansen P
    J Control Release; 2008 Sep; 130(2):161-7. PubMed ID: 18588928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization against leishmaniasis by PLGA nanospheres loaded with an experimental autoclaved Leishmania major (ALM) and Quillaja saponins.
    Tafaghodi M; Eskandari M; Kharazizadeh M; Khamesipour A; Jaafari MR
    Trop Biomed; 2010 Dec; 27(3):639-50. PubMed ID: 21399606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intradermal vaccination with hollow microneedles: A comparative study of various protein antigen and adjuvant encapsulated nanoparticles.
    Du G; Hathout RM; Nasr M; Nejadnik MR; Tu J; Koning RI; Koster AJ; Slütter B; Kros A; Jiskoot W; Bouwstra JA; Mönkäre J
    J Control Release; 2017 Nov; 266():109-118. PubMed ID: 28943194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.